Your browser doesn't support javascript.
loading
Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.
Fortner, Renée T; Schock, Helena; Le Cornet, Charlotte; Hüsing, Anika; Vitonis, Allison F; Johnson, Theron S; Fichorova, Raina N; Fashemi, Titilayo; Yamamoto, Hidemi S; Tjønneland, Anne; Hansen, Louise; Overvad, Kim; Boutron-Ruault, Marie-Christine; Kvaskoff, Marina; Severi, Gianluca; Boeing, Heiner; Trichopoulou, Antonia; Papatesta, Eleni-Maria; La Vecchia, Carlo; Palli, Domenico; Sieri, Sabina; Tumino, Rosario; Sacerdote, Carlotta; Mattiello, Amalia; Onland-Moret, N Charlotte; Peeters, Petra H; Bueno-de-Mesquita, H B As; Weiderpass, Elisabete; Quirós, J Ramón; Duell, Eric J; Sánchez, Maria-Jose; Navarro, Carmen; Ardanaz, Eva; Larrañaga, Nerea; Nodin, Björn; Jirström, Karin; Idahl, Annika; Lundin, Eva; Khaw, Kay-Tee; Travis, Ruth C; Gunter, Marc; Johansson, Mattias; Dossus, Laure; Merritt, Melissa A; Riboli, Elio; Terry, Kathryn L; Cramer, Daniel W; Kaaks, Rudolf.
Afiliación
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schock H; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Le Cornet C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hüsing A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Vitonis AF; Ob/Gyn Epidemiology Center, Brigham and Women's Hospital, Boston, MA.
  • Johnson TS; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fichorova RN; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA.
  • Fashemi T; Laboratory of Genital Tract Biology, Brigham and Women's Hospital, Boston, MA.
  • Yamamoto HS; Laboratory of Genital Tract Biology, Brigham and Women's Hospital, Boston, MA.
  • Tjønneland A; Laboratory of Genital Tract Biology, Brigham and Women's Hospital, Boston, MA.
  • Hansen L; Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Overvad K; Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Boutron-Ruault MC; Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
  • Kvaskoff M; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, F-94805, France.
  • Severi G; Université Paris Sud, UMRS 1018, Villejuif, F-94805, France.
  • Boeing H; Gustave Roussy, Villejuif, F-94805, France.
  • Trichopoulou A; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, F-94805, France.
  • Papatesta EM; Université Paris Sud, UMRS 1018, Villejuif, F-94805, France.
  • La Vecchia C; Gustave Roussy, Villejuif, F-94805, France.
  • Palli D; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, F-94805, France.
  • Sieri S; Université Paris Sud, UMRS 1018, Villejuif, F-94805, France.
  • Tumino R; Gustave Roussy, Villejuif, F-94805, France.
  • Sacerdote C; Human Genetics Foundation (HuGeF), Torino, Italy.
  • Mattiello A; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Onland-Moret NC; Hellenic Health Foundation, Athens, Greece.
  • Peeters PH; Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, WHO Collaborating Center for Nutrition and Health, National and Kapodistrian University of Athens, Athens, Greece.
  • Bueno-de-Mesquita HBA; Hellenic Health Foundation, Athens, Greece.
  • Weiderpass E; Hellenic Health Foundation, Athens, Greece.
  • Quirós JR; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Duell EJ; Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
  • Sánchez MJ; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Navarro C; Cancer Registry and Histopathology Unit, "Civic-M.P-Arezzo" Hospital, ASP Ragusa, Italy.
  • Ardanaz E; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Larrañaga N; Dipartimeno di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Nodin B; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Jirström K; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Idahl A; MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom.
  • Lundin E; Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Khaw KT; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom.
  • Travis RC; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Gunter M; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Johansson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Dossus L; Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.
  • Merritt MA; Public Health Directorate, Asturias, Spain.
  • Riboli E; Cancer Epidemiology Research Program, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain.
  • Terry KL; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
  • Cramer DW; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.
  • Kaaks R; CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.
Int J Cancer ; 142(7): 1355-1360, 2018 04 01.
Article en En | MEDLINE | ID: mdl-29159934

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Autoanticuerpos / Biomarcadores de Tumor / Antígeno Ca-125 / Detección Precoz del Cáncer / Proteínas de la Membrana Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Autoanticuerpos / Biomarcadores de Tumor / Antígeno Ca-125 / Detección Precoz del Cáncer / Proteínas de la Membrana Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Alemania